Skip Navigation


Annals of Oncology Advance Access originally published online on June 18, 2008
Annals of Oncology 2008 19(8):1511-1512; doi:10.1093/annonc/mdn396
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/8/1511    most recent
mdn396v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Azim, H. A.
Right arrow Articles by Goldhirsch, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azim, H. A., Jr
Right arrow Articles by Goldhirsch, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letters to the editors

Anthracyclines for gestational breast cancer: course and outcome of pregnancy

The first 10% of the full text of this article appears below.

Gestational breast cancer (GBC) is a rare disease characterised by an aggressive clinical and biological behaviour [1]. In selected GBC patients, the administration of anthracycline-based regimens was shown to improve outcome [1]; however, the safety of this approach remains of concern. Here, we report the effects . . . [Full Text of this Article]

H. A. Azim, Jr1, F. A. Peccatori1,*, G. Scarfone2, B. Acaia2, P. Rossi2, R. Cascio1 and A. Goldhirsch1

1 Department of Medicine, European Institute of Oncology
2 Division of Obstetrics and Gynaecology, IRCCS Policlinico, Mangiagalli and Regina Elena, University of Milan, Milan, Italy

* (E-mail: fedro.peccatori@ieo.it)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
O. Mir, P. Berveiller, R. Rouzier, F. Goffinet, F. Goldwasser, and J. M. Treluyer
Chemotherapy for breast cancer during pregnancy: is epirubicin safe?
Ann. Onc., September 2, 2008; (2008) mdn553v1.
[Full Text] [PDF]